Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros

Base de dados
Tipo de documento
Intervalo de ano de publicação
1.
Phlebology ; 35(9): 706-714, 2020 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-32611228

RESUMO

OBJECTIVES: Venous thromboembolism is a potentially fatal complication of superficial endovenous treatment. Proper risk assessment and thromboprophylaxis could mitigate this hazard; however, there are currently no evidence-based or consensus guidelines. This study surveyed UK and Republic of Ireland vascular consultants to determine areas of consensus. METHODS: A 32-item survey was sent to vascular consultants via the Vascular and Endovascular Research Network (phase 1). These results generated 10 consensus statements which were redistributed (phase 2). 'Good' and 'very good' consensus were defined as endorsement/rejection of statements by >67% and >85% of respondents, respectively. RESULTS: Forty-two consultants completed phase 1. This generated seven statements regarding risk factors mandating peri-procedural pharmacoprophylaxis and three statements regarding specific pharmacoprophylaxis regimes. Forty-seven consultants completed phase 2. Regarding venous thromboembolism risk factors mandating pharmacoprophylaxis, 'good' and 'very good' consensus was achieved for 5/7 and 2/7 statements, respectively. Regarding specific regimens, 'very good' consensus was achieved for 3/3 statements. CONCLUSIONS: The main findings from this study were that there was 'good' or 'very good' consensus that patients with any of the seven surveyed risk factors should be given pharmacoprophylaxis with low-molecular-weight heparin. High-risk patients should receive one to two weeks of pharmacoprophylaxis rather than a single dose.


Assuntos
Tromboembolia Venosa , Anticoagulantes , Heparina de Baixo Peso Molecular/efeitos adversos , Humanos , Irlanda/epidemiologia , Fatores de Risco , Reino Unido , Tromboembolia Venosa/epidemiologia , Tromboembolia Venosa/etiologia , Tromboembolia Venosa/prevenção & controle
2.
Magy Seb ; 67(5): 297-303, 2014 Oct.
Artigo em Húngaro | MEDLINE | ID: mdl-25327404

RESUMO

INTRODUCTION: The open repair (OR) of infrarenal aortic aneurysm (AAA) has low mortality in tertiary care centres, however, endovascular repair (ER) could be more beneficial for some cases. The aim of our study was to compare the mortality and morbidity of the different AAA repair techniques. MATERIAL AND METHODS: In a single centre retrospective study we evaluated the postoperative complications, the early and late mortality of patients underwent open or endovascular AAA repair. RESULTS: Total of 431 patients underwent OR and 59 had ER. Early mortality was below 2% in both groups (statistically non-significant [NS] difference). Postoperative complications were found in 14.4% in the OR group and 11.9% in the ER group (NS). The intraoperative blood loss and use of blood products were higher, the operation time was significantly longer in the OR group (p < 0.001). The average follow-up time was 37 ± 22 months. Long term mortality and the prevalence of stroke and acute myocardial infarction were similar in both groups. 16% of the patients in the OR group developed incisional hernia. Patients after ER needed further vascular intervention more frequently than patients in the OR group (16.2% vs. 6.2%; p = 0.0327). CONCLUSION: The early and late mortality was similar after open and endovascular AAA repair. Postoperative complications did not show significant difference between the two groups. We found significant difference in the use of blood products, the prevalence of incisional hernias and the number of reinterventions. According to our results, stent graft implantation is mainly recommended in high risk patients and open aortic repair still has a role in the low-moderate operative risk group.


Assuntos
Aneurisma Aórtico/mortalidade , Aneurisma Aórtico/cirurgia , Procedimentos Cirúrgicos Vasculares/efeitos adversos , Procedimentos Cirúrgicos Vasculares/métodos , Idoso , Perda Sanguínea Cirúrgica/estatística & dados numéricos , Implante de Prótese Vascular/efeitos adversos , Implante de Prótese Vascular/métodos , Procedimentos Cirúrgicos Eletivos , Procedimentos Endovasculares/efeitos adversos , Procedimentos Endovasculares/métodos , Feminino , Seguimentos , Hérnia Ventral/epidemiologia , Hérnia Ventral/etiologia , Humanos , Hungria/epidemiologia , Incidência , Masculino , Pessoa de Meia-Idade , Infarto do Miocárdio/epidemiologia , Infarto do Miocárdio/etiologia , Duração da Cirurgia , Reoperação , Estudos Retrospectivos , Stents , Acidente Vascular Cerebral/epidemiologia , Acidente Vascular Cerebral/etiologia , Análise de Sobrevida , Fatores de Tempo , Resultado do Tratamento , Procedimentos Cirúrgicos Vasculares/mortalidade
3.
Magy Seb ; 58(1): 9-15, 2005 Feb.
Artigo em Húngaro | MEDLINE | ID: mdl-16018595

RESUMO

Takayasu's arteritis is a chronic, non-specific inflammation of unknown aetiology, involving the aorta and its main branches. The authors describe the aetiology, pathomechanism, characteristic symptoms and a series of diagnostic criteria. Classifications used in previous decades and nowadays are listed. The therapy--considering the main principles--is individual, and it can be a combination of medical and surgical treatment or percutaneous angioplasty. Takayasu's arteritis is a rare disease in the western countries. There can not be found a specific examination to diagnose it. Mainly in the case of young female patients with inflammation of unknown origin for early diagnosis, it is essential to consider this particular disease.


Assuntos
Arterite de Takayasu , Diagnóstico Diferencial , Feminino , Humanos , Masculino , Prognóstico , Índice de Gravidade de Doença , Fatores Sexuais , Arterite de Takayasu/diagnóstico , Arterite de Takayasu/etiologia , Arterite de Takayasu/patologia , Arterite de Takayasu/fisiopatologia , Arterite de Takayasu/terapia
4.
Magy Seb ; 58(5): 328-30, 2005 Oct.
Artigo em Húngaro | MEDLINE | ID: mdl-16496777

RESUMO

Congenital arteriovenous malformations in the upper extremity, mainly in the hand are rare. In this patient an arteriovenous fistula of the hand caused arterial dilatation of the upper limb, and blunt injury of brachial artery resulted in an extreme large false aneurysm. This situation, which threatened with rupture and peripheral embolisation was treated by resection of the false aneurysm with end-to-end direct anastomosis. Complication of a congenital arteriovenous malformation so late, in the ninth decade is almost exceptional. We think that the successful surgical treatment of an infrequent lesion's rare late complication is worth presenting.


Assuntos
Falso Aneurisma/complicações , Falso Aneurisma/cirurgia , Malformações Arteriovenosas/complicações , Malformações Arteriovenosas/cirurgia , Artéria Braquial , Idoso de 80 Anos ou mais , Artéria Braquial/patologia , Artéria Braquial/cirurgia , Humanos , Masculino , Resultado do Tratamento , Procedimentos Cirúrgicos Vasculares
5.
Magy Seb ; 55(1): 27-30, 2002 Feb.
Artigo em Húngaro | MEDLINE | ID: mdl-11930560

RESUMO

Despite the broadening knowledge about Fournier's gangrene, its mortality rate is still considered very high. The authors describe the etiology, pathomechanism, the possible pathways of progression, and the causes and predisposing factors of the disease. Besides the traditional--surgical and antibiotic--therapy, complementary ways of treatment are described. Between 1994 and 2000, ten patients were treated for Fournier's gangrene in our department. We present our experience, the early signs and the way clinical symptoms develop. It is important to observe the early severe general condition and initially minimal local changes for early diagnosis in improved survival.


Assuntos
Gangrena de Fournier/diagnóstico , Gangrena de Fournier/terapia , Idoso , Idoso de 80 Anos ou mais , Alcoolismo/complicações , Causalidade , Complicações do Diabetes , Fasciite Necrosante/diagnóstico , Fasciite Necrosante/terapia , Feminino , Gangrena de Fournier/tratamento farmacológico , Gangrena de Fournier/microbiologia , Gangrena de Fournier/cirurgia , Humanos , Masculino , Pessoa de Meia-Idade , Estudos Retrospectivos , Fatores de Tempo , Resultado do Tratamento
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA